AstraZeneca Sees Growth Opportunities in Japan As Population Continues To Age
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca KK’s young president Gabriel Baertschi is eying more partnerships for cardiovascular, oncology and respiratory therapies in Japan.